Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2001-09-10
2004-11-02
Saucier, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S533000, C514S006900
Reexamination Certificate
active
06811778
ABSTRACT:
BACKGROUND OF THE INVENTION
Stored blood undergoes a number of deleterious biochemical changes over time, known collectively as “storage lesion.” These changes can include microaggregation of cells, hemolysis, vesicle formation, decreased membrane flexibility, decreased stability, and increased hemoglobin-oxygen affinity. The changes reduce the overall benefit of administering stored blood or red blood cell containing blood products to the patient and may even cause deleterious effects when transfused into a patient. For example, increased microaggregate formation and loss of membrane flexibility of the red blood cells may cause blockage of microcirculatory vessels resulting in local ischemia and pulmonary dysfunction.
Additionally, the loss of 2,3-diphosphoglycerate (2,3-DPG) in red blood cells results in substantially increased hemoglobin-O
2
affinity. Blood stored for greater than one week shows a significant decrease in 2,3-DPG levels. After two weeks, only about 40% of 2,3-DPG remains and by three weeks only about 10% remains. (S. P. Masouredis, Preservation and Clinical Use of Erythrocytes and Whole Blood, Chapter 164, In: Hemology, 3
rd
edition, Williams, Beutler, Erslev and Lichtman, (eds.) McGraw-Hill, NY, pp. 1529-1549 (1983)). The loss of 2,3-DPG produces a concomitant drop in P
50
. For example, after four weeks of storage in the preservative, citrate phosphate dextrose (CPD), the P
50
of packed red cells drops to approximately 15 mm Hg (Wells et al.,
Transfusion
21:709-714 (1981)). Since release of oxygen from red blood cells usually is proportional to P
50
, the capacity of stored red blood cells to deliver oxygen also decreases over time.
Storage lesions can cause deleterious changes in oxygen transport by decreasing both convective and diffusive oxygen delivery. Microaggregates and inflexible cells may be caught in microvessels, blocking flow to downstream tissue. Additionally, red blood cells containing hemoglobin with relatively high oxygen affinity have reduced ability to release oxygen to tissue. Stored red blood cells having high affinity for oxygen can “rejuvenate” over time after transfusion into the body. Levels of 2,3-DPG return to 30% to 50% of normal by four hours and to normal levels with approximately twenty-four hours, though this rate can be variable. (Valeri and Hirsch,
J. Lab. Clin. Med
. 73:722-733 (1969); Beutler and Wood,
J. Lab. Clin. Med
. 74:300-304 (1969)). The rate of 2,3-DPG recovery may be dependent upon the metabolic state of the patient. (O'Brien and Watkins,
J. Thor
. &
Cardiovas. Surg
. 40:611 (1960)). Ironically, stored red blood cells are transfused to meet an acute need, but suffer from acute lesion.
While these cells “rejuvenate” in circulation, regaining flexibility and decreasing oxygen affinity over a period of hours, there is a window of reduced oxygen transport that could adversely affect patients, especially those patients that are critically ill. Furthermore, while young healthy patients may compensate for storage lesion; patients with reduced or absent ability to compensate are put at risk of further injury or reduced efficacy of treatment. Paradoxically, this compensatory response of transfusion of red blood cells having high affinity for oxygen in some cases may cause decreased local oxygenation. (Marik and Sibbald,
JAMA
269:3024-30 (1993)). Production of microemboli is also part of the storage lesion. Microemboli are known to form in packed red cells during storage and on infusion obstruct the microcirculation, causing damage to pulmonary capillary endothelium and alveolar epithelium (Liu, et al.,
Ann. Thorac. Surg
. 54:1196-1202 (1992); Gay, et al., Trauma 19:80-84 (1979)).
Fresh red blood cells have been recommended for massive transfusions, transfusions of infants, older patients, and patients with cardiovascular and pulmonary disease (Masouredis, S. P., Preservation and Clinical Use of Blood and Blood Components,” In: Hemology, (Williams, W. J., Beutler, E., Erslev, A. J. and Lichtman, M. A. eds.) McGraw-Hill, New York, pp. 1529-1549; Sugarman, H. J., et al.
Surg. Gynecol. Obstet
., 131:733-741 (1970); Valeri, G. R., et al.,
Transfusion
20:263-276 (1980); Hess, W.,
Anaesthetist
., 36:455-467 (1987)). However, the availability of fresh blood cells often is limited.
Therefore, a need exists for products and methods that improve the oxygen transport and delivery efficiency of stored red blood cells.
SUMMARY OF THE INVENTION
The present invention is drawn to a method of treating a patient, by administering to the patient stored red blood cells and a hemoglobin solution.
In one embodiment the hemoglobin solution is administered to the patient, and thereafter stored red blood cells are administered, wherein the hemoglobin solution comprises polymerized hemoglobin and wherein the stored red blood cells have been stored for greater than about forty-eight hours.
In another embodiment, the method includes administering stored red blood cells to the patient and thereafter administering a hemoglobin solution within about eight hours of administering the stored red blood cells, wherein the hemoglobin solution comprises polymerized hemoglobin and wherein the stored red blood cells have been stored for greater than about forty-eight hours.
The present invention is further drawn to a composition comprising a hemoglobin solution and stored red blood cells, wherein the stored red blood cells have been stored for greater than about forty-eight hours.
As demonstrated herein, although storage of red blood cells over time reduced the rate of oxygen release from red blood cells, administration of a hemoglobin solution in addition to stored red blood cells reversed this effect and restored oxygen delivery potential to stored red blood cells. The resulting mixture behaved more like fresh red blood cells in oxygen release. Surprisingly, this effect was obtained even when as little as about ten percent (10%) of the total hemoglobin administered to the patient was in the form of hemoglobin solution. As a result of the studies described herein, it is believed that addition of hemoglobin solution in conjunction with stored red blood cells will result in a substantial increase in oxygen release over administration of the same total amount of hemoglobin in the form of freshly isolated red blood cells.
The method and compositions of the present invention can restore oxygen delivery capacity of stored red blood cells more rapidly than may otherwise be possible. The present invention can be particularly useful in the treatment of critically ill, infant, and elderly patients. Furthermore, adding hemoglobin and stored red blood cells according to the method of the present invention will cause increased tissue oxygenation despite the presence of microemboli, because the smaller hemoglobin molecules are able to pass through the obstructions and deliver oxygen. The methods and compositions of the present invention improve the oxygen transport and delivery efficiency of stored red blood cells and can extend the useful storage period of stored red blood cells.
REFERENCES:
patent: 5618919 (1997-04-01), Rausch et al.
patent: 5865784 (1999-02-01), Faithfull et al.
LaMuraglia et al., “The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution”, J. Vascular Surgery 31 (2) : 299-308 (Feb. 2000).*
Slanetz et al., “Hemoglobin blood substitutes in extended peroperative autologous blood donation” An experimental study, Surgery 115 (2) : 246-54(1994).*
Chang, T.M.S., “The Use of Modified Hemoglobin as an Oxygen Carrying Blood Substitute,”Transfusion Medicine Reviews,3 (3) :213-218 (1989).
Homer, L.D. et al., “Oxygen Gradients between Red Blood Cells in the Microcirculation1,”Hypoxia Between Red Cells,pp. 308-323 (1981).
Lovric, V.A., “Alterations in Blood Components during Storage and their Clinical Significance,”Anaesthesia and Intensive Care,12 (3) :246-251 (1984).
Marik, P.E. et al., “Effect of Stored-Blood Transfusion on Oxygen Delivery in Patients With Sepsis,”JAMA,269 (23) :3024-3029 (199
Jacobs, Jr. Edward E.
Light William R.
Page Thomas C.
Biopure Corporation
Hamilton Brook Smith & Reynolds P.C.
Saucier Sandra E.
LandOfFree
Method for improving oxygen transport by stored red blood cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving oxygen transport by stored red blood cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving oxygen transport by stored red blood cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3345387